Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Bionano Genomics interim CEO Albert Luderer acquires 4,000 common shares worth $4,860

Bionano Genomics interim CEO Albert Luderer acquires 4,000 common shares worth $4,860

ReutersReuters2026/08/21 20:31
  • Bionano Genomics interim chief executive Albert Luderer bought 4,000 common shares at $1.22 each.
  • Holding rose to 4,000 shares, owned indirectly through a Traditional IRA.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bionano Genomics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001746822-26-000003), on August 21, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!